Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.41%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 2.12Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information
Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMED PHARMACEUTICALS INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INM - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 4.94M | $ 119.31K | 2.41% |
| 3/31/2025 | $ 4.92M | $ 131.53K | 2.67% |
| 12/31/2024 | $ 4.83M | $ 146.38K | 3.03% |
| 9/30/2024 | $ 4.96M | $ 141.49K | 2.85% |
| 6/30/2024 | $ 4.6M | $ 137.71K | 3% |
| 3/31/2024 | $ 5.63M | $ 139.24K | 2.48% |
| 12/31/2023 | $ 5.49M | $ 134.29K | 2.45% |
| 9/30/2023 | $ 4.72M | $ 186.67K | 3.96% |
| 6/30/2023 | $ 4.14M | $ 278.15K | 6.73% |
| 3/31/2023 | $ 2.34M | $ 414.56K | 17.72% |
Key Performance Insights, Last 5 Years
- INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) SB Comp % stands at 0%.
- Over the past 5 years, INMED PHARMACEUTICALS INC's average SB Comp % has been 40.63%.
- The median SB Comp % for INMED PHARMACEUTICALS INC during this period was 3.96%
- INMED PHARMACEUTICALS INC reached its highest SB Comp % over the past 5 years at 284.46%.
- The lowest SB Comp % recorded by INMED PHARMACEUTICALS INC in the same timeframe 2.41%
INMED PHARMACEUTICALS INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for INMED PHARMACEUTICALS INC is calculated as follows: SB Comp. [ $ 610.19K ] / Revenues [ $ 0 ]
(=) SB Comp % [ 0% ] INM - Stock Based Compensation Margin, Last 5 years
2.41%
Minimum
Jun 30, 2025
284.46%
Maximum
Dec 31, 2021
40.63%
Average
3.96%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.98K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |